Intercept制药(ICPT)

19.00 0.00 0.0%

今开:0.0昨收:19.0
最高:0.0 最低:0.0
涨停价:0.0跌停价:0.0
总市值:7.94693354E8

Intercept制药的最新讨论

liuyunjoey2016-07-20 22:38

$Intercept Pharmaceuticals(ICPT)$ 哪位大神知道奥贝胆酸预计什么时候能通过FDA认证上市销售?查看全文

iRemy2016-06-01 11:32

$Intercept Pharmaceuticals(ICPT)$
#该吃药了#$Intercept Pharmaceuticals(ICPT)$ 
4.65%的上涨幅度,从137.80收于148.36,这是Intercept的Ocaliva通过快速审批通道获得FDA批准的市场反应。 
Intercept成立于2002年,位于纽约市,主要研发方向为慢性肝病的治疗。 
2012-10-16...查看全文

an小安2016-05-29 00:11

$Intercept Pharmaceuticals(ICPT)$
Intercept 的奥贝胆酸获批治疗原发性胆汁性肝硬化(PBC),近20年来首个获批的该类药物。虽然不是NASH适应症,但以获批一个小适应症开始,NASH皆有可能查看全文

an小安2016-04-05 23:13

$Intercept Pharmaceuticals(ICPT)$ intercept大涨,因为FDA外部专家组要讨论奥贝胆酸治疗原发性胆汁性肝硬化(PBC)数据。熊去氧胆酸目前是唯一获批用于 PBC 治疗的药物,但大多数患者的血清标志物碱性磷酸酶(ALP)继续持续性高,增加肝功能衰竭风险,这使得患者需要肝移植。这要是OCA在NASH(非...查看全文

風流倜儻不愛美股2015-10-29 00:25

$Intercept Pharmaceuticals(ICPT)$ 早盘142 143附近 今天没买到的又错过了 [大笑]查看全文

風流倜儻不愛美股2015-10-28 22:57

$Intercept Pharmaceuticals(ICPT)$ 今早抄底它 的都赚最少1000USD查看全文

淡投2015-06-30 08:31

$Intercept Pharmaceuticals(ICPT)$ submits OCA for PBC to FDA and EMA.查看全文

淡投2015-06-08 14:39

$Intercept Pharmaceuticals(ICPT)$
On June 2, Wedbush analyst Liana Moussatos published a list of upcoming catalysts for emerging pharmaceuticals, specifically for Intercept Pharmaceuticals Inc. (ICPT), Receptos Inc. (RCPT), and Omeros Corporation (OMER). Events such as ne...查看全文

淡投2015-05-20 08:52

$Intercept Pharmaceuticals(ICPT)$
Intercept (ICPT) NASH Study to be Larger, Riskier and Delayed, Leerink Partners Says
Leerink Partners analyst Joseph Schwartz weighed in on Intercept Pharmaceuticals (NASDAQ: ICPT) after the company announced the design of Ph.3 REGENE...查看全文

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24

Intercept制药的公告

其他

$Intercept制药(ICPT)$ 15-12G Securities registration termination [Section 12(g)] Accession Number: 0001104659-23-119815  Act: 34  Size: 12 KB 网页链接

生效批准

$Intercept制药(ICPT)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-23-003317  Act: 33  Size: 1 KB 网页链接

生效批准

$Intercept制药(ICPT)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-23-003316  Act: 33  Size: 1 KB 网页链接

生效批准

$Intercept制药(ICPT)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-23-003320  Act: 33  Size: 1 KB 网页链接

持股变动声明

$Intercept制药(ICPT)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-23-117109  Size: 30 KB 网页链接

持股变动声明

$Intercept制药(ICPT)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-23-117105  Size: 21 KB 网页链接

持股变动声明

$Intercept制药(ICPT)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-23-117110  Size: 30 KB 网页链接

持股变动声明

$Intercept制药(ICPT)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-23-117112  Size: 26 KB 网页链接

持股变动声明

$Intercept制药(ICPT)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-23-117106  Size: 28 KB 网页链接

持股变动声明

$Intercept制药(ICPT)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-23-117117  Size: 34 KB 网页链接

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100